Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
CTS CORP | Director | Common Stock | 32.4K | $1.7M | $52.39 | Nov 7, 2024 | Direct |
Calidi Biotherapeutics, Inc. | Director | Common Stock | 133K | $240K | $1.80 | Dec 21, 2023 | Direct |
AMARIN CORP PLC\UK | Director | Stock Option (Right to Buy) | 116K | Jun 27, 2022 | Direct | ||
AMARIN CORP PLC\UK | Director | Restricted Stock Units | 93.8K | Jun 27, 2022 | Direct | ||
Syneos Health, Inc. | Director | Class A Common Stock | 0 | $43.00 | Sep 28, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
CTS | CTS CORP | Nov 7, 2024 | 1 | $0 | 4 | Nov 8, 2024 | Director |
CLDI | Calidi Biotherapeutics, Inc. | Dec 21, 2023 | 1 | $10.2K | 4 | Jan 4, 2024 | Director |
CTS | CTS CORP | Nov 2, 2023 | 1 | $0 | 4 | Nov 6, 2023 | Director |
SYNH | Syneos Health, Inc. | Sep 28, 2023 | 2 | -$150K | 4 | Sep 28, 2023 | Director |
SYNH | Syneos Health, Inc. | May 25, 2023 | 1 | $0 | 4 | May 30, 2023 | Director |
CTS | CTS CORP | Nov 10, 2022 | 1 | $0 | 4 | Nov 14, 2022 | Director |
AMRN | AMARIN CORP PLC\UK | Jun 27, 2022 | 2 | $0 | 4 | Jun 29, 2022 | Director |
SYNH | Syneos Health, Inc. | May 25, 2022 | 1 | $0 | 4 | May 27, 2022 | Director |
AMRN | AMARIN CORP PLC\UK | May 16, 2022 | 2 | $0 | 4 | May 20, 2022 | Director |
AMRN | AMARIN CORP PLC\UK | May 16, 2022 | 0 | $0 | 3 | May 20, 2022 | Director |
SYNH | Syneos Health, Inc. | Jan 18, 2022 | 1 | $0 | 4 | Jan 20, 2022 | Director |
SYNH | Syneos Health, Inc. | Jan 15, 2022 | 0 | $0 | 3 | Jan 20, 2022 | Director |
CTS | CTS CORP | Nov 4, 2021 | 1 | $132K | 4 | Nov 5, 2021 | Director |